One or two intact local summaries. No averaged regimen, patient-specific dose or automatic source preference.
1 local source card selected. Local card fingerprints checked where supplied. This is not an original-document hash, source-currency guarantee or clinical approval. Record-level cautions below are the current library's cautions, not a frozen prior version.
Independent clinical review is pending. Confirm indication, exact formulation/route, population, renal measure and units, kidney-function stability, dialysis prescription, interacting drugs, monitoring and source revision. An RX mirror and its original label are not independent corroboration. Missing disagreement notes do not certify agreement.
The source summary and source table use slightly different boundary notation at CrCl 30. The original indexed table heading and accompanying Cockcroft-Gault formula are retained; renal-function normalization must be confirmed before prescribing.
At the printed value 30, the RX label table places patients in its at-least-30 row, whereas UCSF standard dosing places 30 in its 15-30 row. The RX heading also prints indexed clearance while UCSF uses mL/min.
What to reconcile: Reconcile the renal metric and endpoint before selecting an interval. Do not choose whichever row is more convenient or merge the label dose range with an institutional interval.
Open this note and its source referencesThe ID-directed UCSF CRAB regimen can exceed the routine labeled sulbactam exposure. It has different infusion duration and renal eligibility, and its printed extended-infusion columns leave exactly 60 unassigned.
What to reconcile: Use infectious-disease/antimicrobial-stewardship oversight and the exact infection context. Do not extrapolate this row into unlisted renal or dialysis settings. Keep total combination grams distinct from sulbactam grams.
Open this note and its source referencesUCSF standard adult IV dosing is 3 g every six hours for CrCl above 30 mL/min, every 12 hours at 15-30, and every 24 hours below 15. Its intermittent-hemodialysis regimen is 3 g IV every 12 hours; continuous-hemodialysis dosing is 3 g IV every six hours. For carbapenem-resistant Acinetobacter baumannii, the separate ID-directed extended-infusion row lists 9 g IV every eight hours over four hours only above CrCl 60; lower categories require ID/antimicrobial-stewardship pharmacy guidance. The printed extended-infusion columns leave exactly 60 unassigned. These are total combination grams. Do not extrapolate the specialized regimen into unlisted renal settings or treat all CRRT prescriptions as identical.
RDM36-professional-ampicillin-sulb-ce3d7082f6-C1 · Source locator: Adult non-dialysis table; extended infusion table; intermittent/continuous dialysis table.
This reference does not select a regimen. Complete the indication, measured/estimated renal function and trend, dialysis setting, source rationale, monitoring and reassessment plan in your institution's approved documentation system. Confirm the complete current source before adopting its regimen.
Pinned reference: https://globalrph.com/blogCalcs/renal-dosing-master/compare.php?id=ampicillin-sulb&s1=RDM36-professional-ampicillin-sulb-ce3d7082f6&h1=da1a75b8044f05f72517084817e2a6dbdf92786bf672dd24cd79cb2572bbfe18